Healthcare Industry News: HSMN NewsFeed
News Release - November 27, 2017
Aidoc Receives CE Mark for First Commercial Deep Learning Solution Streamlining Head and Neck Imaging for RadiologistsCompany's Solution Aims at Boosting Radiologists' Efficiency with Targeted AI that Detects Abnormalities in Medical Images and Alerts Doctors in Realtime
TEL AVIV, Israel, November 27, 2017 -- (Healthcare Sales & Marketing Network) -- Aidoc, a leading AI startup utilizing deep learning to augment radiologists' workflow and highlight anomalous cases, which are often highly urgent, today announced that it received CE (Conformité Européenne) marking for the world's first commercial head and neck deep learning medical imaging solution. CE marking allows for widespread commercialization of Aidoc's solution in Europe.
Aidoc's solution augments radiologists' workflow through its unique ability to comprehensively detect abnormalities in imaging of both the head and neck, an anatomical area responsible for a major portion of medical images. Providing significant value for day-to-day diagnosis, time saved by Aidoc's solution could be extremely impactful in trauma cases, where time can be the difference between the patient's life and death.
Aidoc's deep learning technology highlights a vast array of medical findings to help radiologists prioritize readings, aimed at facilitating interpretation and reducing time to decision when it matters most. Radiologists can now perform smart optimization of their worklist by prioritizing cases based on AI medical image analysis in conjunction with other clinically available data. Aidoc's solution is agnostic to radiologists' incumbent software, integrating seamlessly and providing immediate results.
"The amount of medical imaging - especially CT and MR scans - is increasing dramatically, but the number of radiologists has plateaued, creating unsustainable bottlenecks and making the radiologist's already complex work even more challenging," said Aidoc CEO Elad Walach. "Our technology can have a monumental impact augmenting the radiology workflow, aimed at more cost-effective treatment for medical centers and practices, and the healthcare system as a whole. With the CE mark, we have a unique opportunity to update outdated technology for the benefit of hundreds of millions of Europeans."
The CE marking was based on data collected in clinical trials validating Aidoc's precision, which compared the solution's results to unassisted radiologists' review of those cases. Cedars-Sinai Medical Center in Los Angeles also assessed Aidoc's solution earlier this year and that study resulted in impressive accuracy in scan analysis.
"In our clinical trial, Aidoc's technology has demonstrated its ability to enhance our radiologists' workflow, as abnormal scans can be prioritized and more carefully reviewed," said Dr. Barry D. Pressman, MD, Chairman of Imaging at Cedars-Sinai Medical Center. "Our firsthand experience has led me to believe in the technology's potential to achieve a significant increase in our radiologists' productivity and accuracy. It's a win both for our physicians and our patients. Aidoc's AI powered solution will help our radiologists be their best, and streamline their workflow."
Aidoc is a smart radiology company utilizing the most advanced innovations in deep learning and artificial intelligence to augment radiology, with the goal of cutting healthcare costs without sacrificing quality results. Using patent pending technology, Aidoc's state-of-the-art solution analyzes all relevant imaging and clinical data, providing radiologists with highly accurate detection, streamlining workflow and breaking through bottlenecks by allowing them to focus on what they do best, diagnosis. With a team of leading technology experts and industry thought-leaders, Aidoc's vision is to help millions get quicker, highly accurate imaging results. Aidoc is based in Tel-Aviv, Israel. For further information, visit https://aidoc.com/
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.